Envestnet Asset Management Inc Sc Pharmaceuticals Inc. Transaction History

Envestnet Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$4.48 - $6.52 $63,553 - $92,492	14,186 New	14,186 $92,000
Q2 2022 Aug 03, 2022	SELL	$4.3 - $6.48 $43,980 - $66,277	-10,228 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$3.9 - $6.11 $10,350 - $16,215	-2,654 Reduced 20.6%	10,228 $58,000
Q4 2021 Feb 04, 2022	BUY	$3.88 - $6.9 $8,481 - $15,083	2,186 Added 20.44%	12,882 $65,000
Q3 2021 Oct 07, 2021	BUY	$4.93 - $7.15 $52,731 - $76,476	10,696 New	10,696 $71,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $90.2M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.